Matthew E Korenberg
CIK 1649903 · CFO, Treasurer · last filed 2026-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$15.39M
Companies
4
Total Filings
67
Lifetime Open-Market Net
-$12.53M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PVLA | CFO, Treasurer | 1,000 | $157.77 | $157.8K | $0 | 4 | 2026-06-16 |
| LFCR | Director | 69,967 | $5.01 | $350.5K | $0 | 3 | 2026-06-05 |
| LGND | President & COO | 50,777 | $293.15 | $14.89M | -$12.53M | 50 | 2024-09-24 |
| Qualigen Therapeutics, Inc. (QLGN) Delisted | Director | — | $3.21 | — | $0 | 2 | 2022-08-04 |
Recent Filings · Page 5 of 7
67 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-18 | LGND | Tax (F) | −2,309 | -$398.2K | EDGAR |
| 2021-02-05 | LGND | Grant (A) | +10,819 | $0 | EDGAR |
| 2021-01-27 | LGND | Mixed | +4,997 | -$329.3K | EDGAR |
| 2020-07-01 | LGND | Other (J) | +238 | $21.2K | EDGAR |
| 2020-06-08 | Qualigen Therapeutics, Inc. (QLGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-24 | LGND | Tax (F) | −1,166 | -$140.9K | EDGAR |
| 2020-02-18 | LGND | Grant (A) | +6,848 | $0 | EDGAR |
| 2019-12-26 | LGND | Mixed | +2,865 | -$223.8K | EDGAR |
| 2019-09-23 | LGND | Buy (P) | — | $0 | EDGAR |
| 2019-09-03 | LGND | Buy (P) | +500 | $43.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.